There is mounting evidence that decision-making can be affected by treatment in Parkinson's disease. A new study shows that dopamine and deep brain stimulation, two mainstay treatments of Parkinson's, differently affect how patients make decisions weighing rewards against effort costs.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.cub.2024.01.031 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!